Bladder cancer: natural history, tumor markers, and early detection strategies
- PMID: 9259085
- DOI: 10.1002/(sici)1098-2388(199709/10)13:5<299::aid-ssu3>3.0.co;2-8
Bladder cancer: natural history, tumor markers, and early detection strategies
Abstract
Transitional cell bladder carcinoma is characterized by a dichotomous, multichronotopic natural history. Low and moderate grade Ta lesions frequently recur, yet rarely invade, and carry an excellent prognosis with currently available treatments. High grade Ta lesions, tumors with lamina propria invasion (T1), and carcinoma in situ often progress to invasive disease, at which time overall prognosis is significantly decreased, despite various treatment alternatives. Although early detection of bladder tumors, prior to muscle invasion, should vastly improve our ability to save both bladders and lives, current methods of detection are neither sufficiently sensitive nor specific. Tumor marker analysis is an exciting new frontier in bladder cancer evaluation, and may have important applications to early detection strategies, in combination with simple hematuria testing and other selected noninvasive screening methods.
Similar articles
-
Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling.Cancer Res. 2021 Mar 15;81(6):1552-1566. doi: 10.1158/0008-5472.CAN-20-2336. Epub 2021 Jan 20. Cancer Res. 2021. PMID: 33472889
-
Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.J Urol. 2017 Oct;198(4):817-823. doi: 10.1016/j.juro.2017.04.102. Epub 2017 May 6. J Urol. 2017. PMID: 28487100
-
Cell cycle regulators as prognostic factors for bladder cancer.Eur Urol. 1998;33 Suppl 4:11-2. doi: 10.1159/000052253. Eur Urol. 1998. PMID: 9615199 Review. No abstract available.
-
[Prognostic factors in urothelial carcinoma].Urologe A. 2001 Nov;40(6):442-6. doi: 10.1007/s001200170002. Urologe A. 2001. PMID: 11760346 Review. German.
-
Predicting disease outcome of non-invasive transitional cell carcinoma of the urinary bladder using an artificial neural network model: results of patient follow-up for 15 years or longer.Int J Urol. 2003 Mar;10(3):149-52. doi: 10.1046/j.1442-2042.2003.00589.x. Int J Urol. 2003. PMID: 12622711
Cited by
-
Fluorocoxib A loaded nanoparticles enable targeted visualization of cyclooxygenase-2 in inflammation and cancer.Biomaterials. 2016 Jun;92:71-80. doi: 10.1016/j.biomaterials.2016.03.028. Epub 2016 Mar 21. Biomaterials. 2016. PMID: 27043768 Free PMC article.
-
PSMA-Targeting Positron Emission Agents for Imaging Solid Tumors Other Than Non-Prostate Carcinoma: A Systematic Review.Int J Mol Sci. 2019 Oct 2;20(19):4886. doi: 10.3390/ijms20194886. Int J Mol Sci. 2019. PMID: 31581638 Free PMC article.
-
Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions.Int J Mol Sci. 2021 Nov 28;22(23):12864. doi: 10.3390/ijms222312864. Int J Mol Sci. 2021. PMID: 34884669 Free PMC article. Review.
-
Targeting Pancreatic Cancer Cells with Peptide-Functionalized Polymeric Magnetic Nanoparticles.Int J Mol Sci. 2019 Jun 19;20(12):2988. doi: 10.3390/ijms20122988. Int J Mol Sci. 2019. PMID: 31248076 Free PMC article.
-
Preparation and characterization of gelatin-based mucoadhesive nanocomposites as intravesical gene delivery scaffolds.Biomed Res Int. 2014;2014:473823. doi: 10.1155/2014/473823. Epub 2014 Dec 15. Biomed Res Int. 2014. PMID: 25580433 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical